Patents for C12R 1 - Micro-organisms (92,025)
02/2003
02/05/2003EP1281404A2 Use of antibodies against the urokinase receptor
02/05/2003EP1281063A1 Grating optical waveguide structure for multi-analyte determinations and the use thereof
02/05/2003EP1280921A1 Bacterial carboxypeptidase cpg2 variants and their use in gene directed enzyme prodrug therapy
02/05/2003EP1280892A2 ISOLATION AND EXPRESSION OF A GENE FOR A NITRILASE FROM i ACIDOVORAX FACILIS 72W
02/05/2003EP1280812A1 Cyclipostins, a method for their production and the use of the same
02/05/2003EP1280543A2 Process for producing, methods and compositions of glucuronoxylomannan as nutriceutical agent from higher basidiomycetes mushroom
02/05/2003EP1200101A4 Methods for transdifferentiation of body tissues
02/05/2003EP0907723A4 Enzyme composition for tissue dissociation
02/05/2003EP0862645B1 Stereoselective microbial reduction process
02/05/2003EP0837634B1 Novel Bacillus thuringiensis pesticidal substance
02/05/2003CN1395620A Cell isolation method
02/05/2003CN1395615A Microorganisms producting L-glutamine and process for producing L-glutamine using the same
02/05/2003CN1394961A Method for mass production of taxinol by utilizing batch or semi-continuous culture
02/05/2003CN1100877C Pencillin V. amidohydrrolase gene from fusarium oxysporum
02/05/2003CN1100876C DNA encoding human paplilloma virus type 18
02/05/2003CN1100874C DNA coding for phosphoenlopyravate carboxkinase, recombinant carrier contg. same, and plant cell
02/04/2003US6515205 Genes from chromatium vinosum for the production of polyhydroxyalkanoate
02/04/2003US6515201 Nuclleotide sequences coding enzymatic polypeptide; for use in controlling preferential gene expression in plants
02/04/2003US6515170 Enzymatic oxidative deamination process
02/04/2003US6515107 Human metabotropic glutamate receptor 7 subtypes
02/04/2003US6514943 Method and composition for preserving viruses
02/04/2003US6514761 Methods of using BCL-2 for the therapeutic treatment and prevention of diseases
02/04/2003US6514756 Human myoblast cell lines and their uses
02/04/2003US6514754 Of herpesvirus of turkeys (HVT) inserted in a non-essential region of the vector; may be manipulated to provide vaccines
02/04/2003US6514749 Culture of Rhinocladiella which degrades mycotoxins; can be used to control fungal diseases in crop agriculture and improve food grain quality
02/04/2003US6514742 D-aminoacylases, method for producing the same, and method for producing D-amino acids using the same
02/04/2003US6514740 Esterase gene and its use
02/04/2003US6514733 Process for the biological production of 1,3-propanediol with high titer
02/04/2003US6514690 Immunoreactive antigens of Hepatitis E Virus
02/04/2003US6514494 Bacterial strain, processed plant extracts, compostions containing same, processes for their preparation and their therapeutic and industrial applications
02/04/2003CA2164692C Recombinant spider silk analogs
02/04/2003CA2116126C Process for controlling lepidopteran pests
02/04/2003CA2109815C Antibody preparation
02/04/2003CA2063810C Production of vascular endothelial cell growth factor
02/04/2003CA2060325C Polypeptides with a dopaminergic receptor activity; nucleic acids coding for these polypeptides and use of the latter for screening active substances on said polypeptides
01/2003
01/30/2003WO2003008618A2 Glucans and glucansucrases derived from lactic acid bacteria
01/30/2003WO2003008575A2 Dna sequences for regulating transcription
01/30/2003WO2002088373A3 Method for producing an aqueous acrylamide solution with a biocatalyst
01/30/2003US20030023997 Transgenic c. elegans as a model organism for investigations on alzheimer's disease
01/30/2003US20030022349 Virulence-associated nucleic acid sequences and uses thereof
01/30/2003US20030022348 Modified forms of pullulanase
01/30/2003US20030022323 Generation of 1,3-propanediol; obtain microorganism, transform with vector, propagate in nutrient broth, express vector, recover propanediol
01/30/2003US20030022321 Novel compounds
01/30/2003US20030022320 Nucleic acid sequences coding polypeptide for use in the generation of preferential amino acids, for use in animal nutrients, pharmocology and medicines
01/30/2003US20030022308 Fusion polypeptides of human serum albumin and a therapeutically active polypeptide
01/30/2003US20030022273 Fermentative carotenoid production
01/30/2003US20030022181 Streptococcus pneumoniae antigens
01/30/2003US20030022156 Transducing Phages
01/30/2003US20030021811 Modulating production of pneumococcal capsular polysaccharide
01/30/2003US20030021781 Administering antibodies
01/30/2003CA2454563A1 Glucans and glucansucrases derived from lactic acid bacteria
01/29/2003WO2002010350A1 Method of proliferating natural killer cells
01/29/2003EP1279727A1 Transformation and modification of natural drug by intestinal probiotic fermentative culture
01/29/2003EP1279678A1 Gag antigen and other orf fragments of lav virus. Use for the detection of lav infection and in immunogenic compositions
01/29/2003EP1278885A1 Resolution of aminotetralins
01/29/2003EP1278882A1 Overproduction hosts for biosynthesis of polyketides
01/29/2003EP1278881A1 Hybrid glycosylated products and their production and use
01/29/2003EP1278880A1 Process for the preparation of alkaline earth salts of d-pantothenic acid
01/29/2003EP1278876A2 STABLE i ZYMOMONAS MOBILIS /i XYLOSE AND ARABINOSE FERMENTING STRAINS
01/29/2003EP1278873A1 Fermentative production of ethanol by heterologous expression of a pyruvate decarboxylase gene in bacillus sp
01/29/2003EP1278868A2 Novel mutated form of arginine deiminase
01/29/2003EP1278867A2 Hcv ns2/3 fragments and uses thereof
01/29/2003EP1278854A2 Compositions and methods for the therapy and diagnosis of acne vulgaris
01/29/2003EP1278853A2 Listeria monocytogenes genome, polypeptides and uses
01/29/2003EP1278778A2 Modified peptides, comprising an fc domain, as therapeutic agents
01/29/2003EP1278772A2 Glucagon antagonists
01/29/2003EP1278725A1 Process for extracting astaxanthin pigment from yeast and extracted pigment thereof
01/29/2003EP1220940B1 Method for production of l-cysteine or l-cysteine derivatives by fermentation
01/29/2003EP0915988B1 Process for the fermentative production of deacylated cephalosporins
01/29/2003EP0769909B1 Novel dipteran-active compound and bacillus thuringiensis strains
01/29/2003EP0703980B1 Intracellular binding proteins and use thereof
01/29/2003CN1394235A Method for detection of pathogenic organisms
01/29/2003CN1393556A Active recombination D-glycolylurea
01/29/2003CN1099894C Vaccine composition for eliciting immune response against N-glycolylated gangliosides and its use
01/29/2003CA2417579A1 Method of proliferating natural killer cells
01/28/2003WO2002010356A2 Novel amylolytic enzyme extracted from bacillus sp. a 7-7 (dsm 12368) and washing and cleaning agents containing this novel amylolytic enzyme
01/28/2003US6512104 Interleukin-1β converting enzyme like cysteine protease
01/28/2003US6512096 Prostate cell surface antigen-specific antibodies
01/28/2003US6512008 Substance WK-5344A and wk-5344B and process for producing the same
01/28/2003US6511841 Streptomyces avermitilis gene directing the ratio of B2:B1 avermectins
01/28/2003US6511823 Novel DNA and amino acid sequences; expression vectors and host cells useful in a method for production of the HBNF protein
01/28/2003US6511820 Bacterial strains for the production of Pyrroloquinoline Quinone
01/28/2003US6511661 A probiotic formulation of Escherichia coli strain BU-230-98 ATCC Deposit No. 20226 (DSM 12799); containing at least one volatile fraction (VF) of a plant extract
01/28/2003CA2417547A1 Novel amylolytic enzyme extracted from bacillus sp. a 7-7 (dsm 12368) and washing and cleaning agents containing this novel amylolytic enzyme
01/28/2003CA2077590C Recombinant dna coding for a protein with endochitinase activity
01/24/2003WO2002010422A1 Method for the enantioselective reduction of 8-chloro-6-oxo-octanoic acid alkyl esters
01/24/2003CA2417119A1 Method for the enantioselective reduction of 8-chloro-6-oxo-octanoic acid alkyl esters
01/23/2003WO2003006649A2 Expression system
01/23/2003WO2003006631A1 Leguminous bacterium having potentiated nitrogen fixation ability
01/23/2003WO2003006602A2 Subtilase variants
01/23/2003WO2002070685A3 Method of modifying the genome of gram-positive bacteria by means of a novel conditionally negative dominant marker gene
01/23/2003WO2002055015A3 Rapid antibiotic susceptibility test
01/23/2003WO2002012272A3 Therapeutic anti-melanoma compounds
01/23/2003WO2001090337A3 Detection of rna
01/23/2003WO2001090333A3 Recombinant bacterial phytases and uses thereof
01/23/2003WO2001075174A3 Detection and typing of human papillomavirus using pna probes
01/23/2003US20030017973 Fraction extracted from archaebacteria for cosmetic purposes
01/23/2003US20030017967 Insecticides; microbiocides; for plants, seeds
01/23/2003US20030017571 Polynucleotide compositions encoding broad spectrum delta-endotoxins
01/23/2003US20030017557 Nucleotide sequences coding amino acid for use in human medicines and nutrient broths